Imperial Brands PLC IMB.L
Composite 48/100; the shares have moved about 24% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 19/100 — a strong mark against it.
Income ranks 87/100 — a strong point in its favour. Valuation ranks 77/100 — a strong point in its favour. Quality ranks 65/100 — a moderate point in its favour.
Balance-sheet strength ranks 19/100 — a strong mark against it. Momentum ranks 25/100 — a strong mark against it. Growth ranks 28/100 — a moderate mark against it.
What the company does Imperial Brands PLC (IMB.L) is a global tobacco and next-generation products (NGP) company, selling cigarettes, vapour, heated tobacco, and oral nicotine under brands like Davidoff, Gauloises, and Blu. It also distributes third-party tobacco and NGP products, operates logistics, and provides non-tobacco services such as printing and golf course management.
Key financials IMB.L reports strong profitability metrics: ROE 37.1%, ROA 7.8%, and ROCE 41.0%. Margins are robust (Gross 36.3%, Operating 16.0%, Net 9.0%), though EPS growth is negative at -38.2%. Debt levels are high (Debt/Equity 2.44), but interest coverage stands at 7.72x. Dividend yield is 5.8% with a 75.4% payout ratio.
Stock health The stock shows mixed momentum: up 5.72% over 3 months but down -3.24% over 6 months, with an RSI(14) of 65.50. Valuation metrics are attractive (P/E 8.05 forward, EV/EBITDA 8.34), but liquidity is weak (Current ratio 0.70). Quality scores are high (71.7/100), while growth lags (27.8/100).
Price vs fair value The stock trades at a **discount** of 137.80% to our fair-value estimate and a **discount** of 13.13% to the analyst 12-month target. - High profitability (ROE 37.1%, ROCE 41.0%) supports valuation (Sideravia). - Negative EPS growth (-38.2%) and weak 6-month momentum (-3.24%) may explain the discount (Key Financials). - Attractive forward P/E (8.05) and EV/EBITDA (8.34) suggest undervaluation (Valuation).
Looking forward Forward P/E (8.05) and PEG (0.12) imply deep undervaluation, but weak growth (27.8/100) and high debt (Debt/Equity 2.44) temper enthusiasm. Dividend yield (5.8%) remains a key appeal. Analysts’ 12-month target (3313.64) suggests ~13% upside from the current price.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.